INTRODUCTION
Neutrophils are the most abundant immune cells in the bloodstream. They are essential for survival; in humans a lack of neutrophils results in severe immunodeficiency and a drastically reduced lifespan, as for example in individuals with mutations causing congenital neutropenias (Klein, 2011) . Neutrophils are produced in the bone marrow from dividing progenitors. After maturing and exiting the cell cycle they move to the circulatory system where they are thought to have a short lifespan. Upon infection or injury they migrate into affected tissues where they directly kill pathogens, as well as shaping the ensuing adaptive immune response (Amulic et al., 2012; Mantovani et al., 2011) .
Neutrophils kill microbes by phagocytosis, production of reactive oxygen species (ROS), and by release of various microbicidal proteins. Before activation, these antimicrobials are kept in intracellular storage vesicles called granules. When the cell senses pathogens, the antimicrobials can be released by a process called degranulation, whereby the granules fuse with the plasma membrane and release their contents. An additional antimicrobial strategy has been described, which entraps pathogens in neutrophil extracellular traps (NETs) (Brinkmann et al., 2004) . These consist of extruded chromatin bound to various antimicrobials from the granules. By associating with NETs, the antimicrobial molecules are physically limited from diffusing away from their site of action, which may enhance their killing capacity, as well as limit collateral damage to host tissues. NETs are triggered by large pathogens, such as hyphal forms of Candida albicans (Branzk et al., 2014) . Furthermore, excessive NET release is associated with a growing list of inflammatory and autoimmune diseases, including systemic lupus erythematosus (SLE) (Kaplan and Radic, 2012) , atherosclerosis (Warnatsch et al., 2015) , diabetes (Wong et al., 2015) , vasculitis (Kaplan and Radic, 2012) , thrombosis (Martinod and Wagner, 2014) , sepsis (Camicia et al., 2014) , and cancer (Park et al., 2016) . Understanding the molecular mechanism of NET formation is thus crucial for developing therapeutics in the context of immune defense and inflammatory diseases.
NETosis is a type of neutrophil cell death, distinct from apoptosis or necrosis, which remains poorly characterized. It is an active process characterized by internal breakdown of nuclear and granular membranes, the mixing of the contents of these compartments in the cytosol and finally, their extracellular release via plasma membrane rupture (Fuchs et al., 2007) . Although alternative pathways have been reported (Park et al., 2016; Parker et al., 2012; Kenny et al., 2017) , the most studied NETosis program is the one in response to C. albicans and the mitogen phorbol myristate acetate (PMA). It requires signaling through mitogen-activated protein kinases (MAPKs) (Hakkim et al., 2011) and the production of ROS by the enzyme NADPH oxidase (NOX2) (Fuchs et al., 2007) . ROS are required for the permeabilization of granules by a protein complex called the azurosome, which allows translocation of a protease, neutrophil elastase, into the nucleus where it cleaves histones and leads to chromatin decondensation (Papayannopoulos et al., 2010; Metzler et al., 2014) . Other mechanistic aspects remain unknown, although some forms of NET formation are associated with citrullination of histones, catalyzed by the enzyme protein arginine deiminase 4 (PAD4) (Li et al., 2010; Kenny et al., 2017) .
One of the most distinctive features of NETosis is the breakdown of the nuclear envelope. This characteristic sets it apart from apoptosis, and is highly reminiscent of nuclear envelope disintegration during mitosis in dividing cells. This observation led us to postulate that NET induction is linked to mitogenic reactivation of cell-cycle regulators. We show that neutrophils, which are terminally differentiated cells, upregulate Ki-67, phosphorylate retinoblastoma protein (pRb), and nuclear lamins, and separate centrosomes without replicating DNA or undergoing cytokinesis. We demonstrate that core members of the cell-cycle machinery, cyclin-dependent kinases 4 and 6 (CDK4/6), are required for NET formation. Taken together, the data presented here show that, in neutrophils, cell-cycle pathways are repurposed for controlling NETosis.
RESULTS

Mitogens Induce NETs
Fungi and the protein kinase C agonist PMA activate a similar pathway to make NETs. Both induce MAPK signaling (Hakkim et al., 2011) , the activation of NOX2, and the production of ROS (Fuchs et al., 2007) . PMA is also a strong mitogen, a chemical with the ability to trigger cell division. We tested if other mitogens also lead to NET release. Concanavalin A (ConA) and phytohaemagglutinin, two plant lectins commonly used to induce proliferation of lymphocytes, both induced NETs, distinguishable by their morphology and the colocalization of nuclear and granular markers (Figures 1A and 1B) . Importantly, NET induction with mitogens was also dependent on ROS production, since neutrophils isolated from chronic granulomatous disease (CGD) patients, who have deficiencies in NOX2, or those treated with diphenyleneiodonium, a NOX2 chemical inhibitor, did not undergo NETosis (Figures 1A and 1B) .
NETosis Is Accompanied by Induction of Cell Division Markers
Neutrophils are terminally differentiated cells that have withdrawn from the cell cycle and lost their capacity to divide. Indeed, mature neutrophils downregulate most of the genes involved in cell-cycle regulation (Klausen et al., 2004) , a finding we confirmed by genome-wide expression analysis of peripheral blood neutrophils from healthy donors (Table S1 ). Despite this, mitogenic stimulation of neutrophils leads to nuclear envelope breakdown as it does in the case of mitosis in dividing cells. Transmission electron microscopy comparing mitosis in the myeloid cell line PLB-985, and NETosis in neutrophils, revealed that the vesiculation of the nuclear envelope is common to both processes ( Figure 1C ; Fuchs et al., 2007) . We were struck by this similarity and postulated that common cellular pathways are employed during NETosis and mitosis.
We first examined cell-cycle markers in neutrophils induced to make NETs. The nuclear antigen Ki-67 is expressed in all cycling cells, irrespective of the stage of the cell cycle they are in, while it is absent in non-cycling, quiescent, or senescent cells. Resting neutrophils were negative for Ki-67 but, surprisingly, cells stimulated to undergo NETosis transiently reactivated expression of this cell division marker, visualized by immunofluorescence ( Figures 2A and 2B ).
We examined a series of other cell-cycle markers, in the order in which they are induced in dividing cells. Neutrophils are typically considered to be in the G 0 stage, like other terminally differentiated and quiescent cells ( Figure S1 ). Cells in G 0 can resume cycling after mitogenic stimulation; this is associated with phosphorylation of pRb by CDK4/6 (Malumbres and Barbacid, 2009) . Notably, neutrophils stimulated to make NETs also exhibited robust phosphorylation of pRb, indicating that activation of G1 kinases was occurring ( Figure 2C ). Importantly, pRb phosphorylation was not only triggered by PMA and ConA, but also by infection with C. albicans hyphae ( Figure 2C ). Stimuli that activate neutrophils but do not induce NETs, such as bacterial peptide analog N-formylmethionyl-leucyl-phenylalanine (fMLP), did not lead to pRb phosphorylation.
Despite activation of G1 kinases, we did not detect incorporation of the thymidine analog 5-ethynyl-2 0 -deoxyuridine (EdU) ( Figure 2D ), indicating that DNA synthesis, the hallmark of S phase, did not occur. As a control for EdU incorporation we used continuously cycling HEK293 cells ( Figure 2D ) as well as T lymphocytes, which can be induced to proliferate by treatment with PMA, analogously to our stimulation of neutrophils. T cells stimulated with PMA/ionomycin successfully incorporated EdU, but this required a longer period of stimulation than the 3 hr it took neutrophils to make NETs ( Figure S1B ), highlighting an important difference in the temporal dynamic between NETosis and cell-cycle re-entry. Similarly, we observed no induction of the S-phase transcriptional program in neutrophils making NETs. In cycling cells, phosphorylation of pRb leads to the derepression of E2F transcription factors and expression of S-phase genes, but these were not induced in NETosis as measured by qPCR analysis ( Figure S1C ) and whole-genome microarray analysis (data not shown).
Our initial observation of nuclear envelope breakdown during NETosis ( Figure 1C ) argued that mitotic pathways are also activated. In mitosis (M phase), nuclear envelope disintegration is triggered by phosphorylation of lamins, intermediate filament proteins that form a sheet underneath the envelope called the nuclear lamina (Heald and McKeon, 1990) . Phosphorylation of the lamina disrupts the structural rigidity of the nucleus, allowing the nuclear envelope to disintegrate. We tested if NET formation is also associated with phosphorylation of lamins. Remarkably, treatment with the NET-inducing stimuli PMA, ConA, or C. albicans hyphae all led to robust phosphorylation of lamin A/C ( Figure 2C ). This was confirmed by immunofluorescence ( Figures S1D and S1E ). Furthermore, NETosis was accompanied by induction of a second mitotic marker: phosphorylation of histone H3 at serine 10 (H3S10). Neither lamin nor H3S10 phosphorylation were induced by the control stimulus fMLP ( Figure 2C ), which, as mentioned above, does not induce NETs.
Induction of NETs Leads to Centrosome Separation
To test whether NET formation involves induction of other mitotic markers, we visualized microtubule dynamics by immunofluorescence microscopy. During mitosis, microtubule-based structures called centrosomes, which were duplicated in the preceding S phase, separate and migrate to opposing poles of the cell where they nucleate formation of the mitotic spindle (Mardin and Schiebel, 2012) . In unstimulated neutrophils, immunostaining with an antibody directed against both aand (B) Quantification of NET induction with mitogens and C. albicans, and inhibition with the NOX2 inhibitor diphenyliodonium (DPI, 5 mM). Representative result of three independent repeats, means ± SD. (C) Electron micrograph comparing nuclear envelope breakdown in mitosis and NETosis. Left: PLB-985 cells were synchronized in G2 and then released into mitosis. In G2 the nuclear envelope is intact but disintegrates in the prophase of mitosis, concurrently with appearance of condensed chromosomes (darker staining territories in the nucleus). In anaphase, chromosomes have separated and, eventually the nuclear envelope begins to reform. Right: nonstimulated neutrophils have a lobulated nucleus, but this lobulation is lost as they prepare to release NETs. Approximately 2 hr after PMA stimulation, the nuclear envelope starts to disintegrate, allowing nuclear material to mix with the contents of the granules and the cytoplasm before being released into the extracellular space. The bottom row shows magnified details from corresponding top panels. Arrows indicate vesiculation of the nuclear envelope. Neutrophil images are representative from at least five different embeddings. Scale bars, 5 mm (upper panels; overview) and 1 mm (lower panels; detailed views). b-tubulin demonstrated a ''skeletal'' or scaffold-like staining pattern with several filaments extending from a central microtubule-organizing center (Figures 2E and S1F). After 30 min of PMA stimulation these extended filaments were lost and rearranged into single or double dot-like structures. Strikingly, 60 min post-stimulation, these dot-like structures had duplicated and migrated away from each other. The structures were most fully separated from each other at 90 min post-stimulation and were no longer present by 120 min, which coincided with breakdown of the nuclear envelope. Immunofluorescence detection of the centrosome marker g-tubulin confirmed that these structures were bona fide centrosomes ( Figures 2F and 2G ). Treatment with the control stimulus fMLP did not induce microtubule rearrangement ( Figure S1G ). Centrosome separation, together with phosphorylation of lamins and histone H3S10, demonstrate that markers of a mitotic program are present just before neutrophils die and release NETs.
Neutrophils Activate Cell-Cycle Signaling In Vivo
Induction of cell-cycle markers in neutrophils was surprising since they are terminally differentiated cells. To verify that this also occurs in vivo, we induced NETs by inoculating mice with C. albicans via the orotracheal route. We then co-stained lung sections with antibodies against neutrophil markers (calgranulin A or Ly6G) and the cell division marker Ki-67. Interestingly, we identified many Ki-67-positive neutrophils in the infected lungs ( Figures 3A and S2A ). We also examined human histological sections from patients with brain fungal abscesses, identified by periodic acid-Schiff staining ( Figure S2B ). We observed NETs in these sections by detecting neutrophil elastase co-localizing with DNA ( Figure S2C ). Next, we co-stained sections with Ki-67 and the neutrophil marker calgranulin, and indeed were able to observe Ki-67-positive neutrophil infiltrates ( Figure 3B ). We confirmed this finding using immunohistochemical methods with a second Ki-67 antibody ( Figure S2D ), as well as immunofluorescentbased detection of a second neutrophil marker (CD66b; Figure S2E) . Neutrophils were only Ki-67 positive when they had intact nuclei (NET precursors), as was the case with Ki-67 detection in purified neutrophils ( Figure 2B ). Remarkably, we could also detect duplicated centrosomes in these cells ( Figure 3C ), demonstrating the induction of mitotic pathways in neutrophils in vivo and confirming our results with isolated human cells.
The Cell-Cycle Inhibitor p21 cip Regulates NET Formation Human neutrophils are refractory to transfection and gene editing because of their short lifespans. As an initial approach to determine whether NETosis is dependent on the cell cycle, we used cell-penetrating peptides. In dividing cells, one class of negative cell-cycle regulators is a family of small proteins termed cip/kip (CDK interacting protein/Kinase inhibitory protein). The prototype of this family is p21 cip1 (p21), a protein that blocks the cell cycle at several different points ( Figure S1A ) by inhibiting cyclin-CDK complexes. We synthesized a peptide mimic corresponding to the CDK inhibitory domain of p21 (Rousseau et al., 1999) , which was previously shown to inhibit proliferation by interfering with the activity of CDKs. We coupled this peptide to the cell-penetrating tat sequence (Goulvestre et al., 2005) . A scrambled peptide served as the control. Both peptides penetrated neutrophils with similar efficiencies ( Figure S3A ), and neither were toxic to the cells ( Figure S3B ). Transduction of the p21 inhibitory peptide (p21inh) into human neutrophils completely blocked NET formation, while transduction of the control scrambled peptide (p21ctrl) had little effect (Figures 4A and 4B) . Interference with CDKs thus leads to inhibition of NET release, indicating that these cell-cycle regulators are necessary for NETosis. We also examined NET formation in p21 knockout mice, whose cells have higher proliferative capacities due to increased CDK activity and loss of cell-cycle control (Bedelbaeva et al., 2010) . As expected, peritoneal neutrophils from p21 knockout mice made more NETs than wild-type (WT) cells ( Figure 4C ), consistent with p21 being a regulator of both cell-cycle and NET formation. ROS production, however, was similar in both strains ( Figure 4D ).
Neutrophils Express CDK4/6
The early stages of NET formation display various cell-cycle markers and can be blocked by the CDK binding domain of the p21 cell-cycle inhibitor. CDKs and their regulatory subunits, the cyclins, are the major drivers of the mammalian cell cycle ( Figure S1A ). The CDKs are a large group of kinases, many of which have functions unrelated to the cell cycle (Lim and Kaldis, 2013) . Of the canonical cell-cycle regulatory kinases, the close homologs CDKs 4 and 6 regulate the transition from G 0 to G 1 phase and are considered to be largely redundant (Malumbres and Barbacid, 2009 ). CDK2 drives progression through S phase, while CDK1 is essential for mitosis, although much functional overlap has been reported ( Figure S1A ; Malumbres and Barbacid, 2009 ). We examined protein expression of the cell-cycle CDKs in human neutrophils and were able to detect CDK4/6 ( Figure 5A ). CDK4 was present at the protein level, as well as induced at the transcriptional level, after NET induction (Figure S4A) , while CDK6 was only present at the protein level (Figure 5A) . Neutrophils did not express CDK2 or CDK1 ( Figures 5A   and S4A ), in agreement with previous reports (Leitch et al., 2012; Klausen et al., 2004) .
CDK4/6 are implicated in phosphorylation of pRb (Meyerson and Harlow, 1994) and in centrosome separation (Hussain et al., 2013) both of which occur during NET formation ( Figures  2C and 2F ). Furthermore, CDK4/6 activity can be induced via MAPK signaling and is a central link between extracellular growth signals and induction of proliferation (Malumbres and Barbacid, 2009 ). CDK6 localizes throughout the cytoplasm in unstimulated neutrophils and transiently accumulates in the nucleus of PMA-stimulated cells ( Figure 5B ). We could not determine the localization of CDK4. Neutrophils express the CDK4/6 regulatory co-factor cyclin D2 and low levels of cyclin D3 ( Figure 5C ).
CDK4/6 Controls NET Formation
To test if these G1 kinases are involved in NET formation, we incubated human neutrophils with a CDK4/6 pharmacological inhibitor (abemaciclib/LY2835219), which efficiently blocked NETs in a dose-dependent manner (Figures 5D, S4D, and S4E ), but did not inhibit the oxidative burst ( Figure 5F ), phagocytosis (Figure 5G ), or degranulation ( Figure S4F ). This was confirmed with a second Cdk4/6 inhibitor (palbociclib, Figure 5E ). Both inhibitors blocked ConA-induced NETs at lower concentrations than those required for PMA, consistent with ConA being a weaker stimulus. CDK4/6 inhibition blocked translocation of elastase to the nucleus ( Figure S4G ), a requirement for NET release (Papayannopoulos et al., 2010) . CDK4/6 double knockout mice die at late stages of embryonic development due to severe anemia (Malumbres et al., 2004) Cdk6 À/À mouse strain in which expression of the gene was interrupted by insertion of a floxed transcriptional stop cassette in the first exon (Hu et al., 2009) . We purified neutrophils from the peritoneum of Cdk6 À/À and WT mice ( Figure S5A ) and obtained similar yields and purities ( Figure S5B ). Like human neutrophils, mouse neutrophils expressed Cdk4 as well as Cdk6 ( Figure S5A ). Despite this redundancy, Cdk6-deficient neutrophils were impaired in NET production in response to both PMA and C. albicans hyphae (Figures 5H and S5C ). We obtained similar results with bone marrow-purified neutrophils ( Figure S5D ). The oxidative burst was unaffected in the knockout animals ( Figure 5I ), similar to the result with the CDK4/6 inhibitor. There was no difference in peritoneal neutrophil maturity between the two genotypes, as revealed by expression level of the surface marker Ly6G ( Figure S5E ) and nuclear morphology ( Figure S5F) . Likewise, we observed no difference in cytokine production ( Figure 5J ), indicating that Cdk6 deficiency specifically affects NET production, rather than generally modulating inflammatory pathways.
Cdk6 Is Required for Antifungal Defense In Vivo
To test the effect of Cdk6 and NET deficiency in infections, we used the murine C. albicans sepsis model, which closely reflects the human disease (Spellberg et al., 2005) . In this model, C. albicans colonizes the kidneys leading to renal failure (Spellberg et al., 2005) . The host anti-Candida response is mediated primarily by neutrophils (Fulurija et al., 1996) , making this a good model for investigating the effect of Cdk6 and NET deficiency on immunity. Mice were intravenously injected with live C. albicans and monitored over the course of the infection. Cdk6 À/À animals lost weight more rapidly than WT animals (Figure 6A) and also succumbed to the disease more rapidly than WT animals ( Figure 6B ). Nox2-deficient animals, which are similarly impaired in NET production, also showed reduced survival in response to C. albicans challenge ( Figure 6B ).
We next infected mice with a sublethal dose of C. albicans and compared fungal loads in the kidneys 5 days post-infection. We found a strikingly elevated C. albicans fungal load in knockout animals ( Figure 6C ). This effect was not due to differences in peripheral blood counts of neutrophils ( Figure S6A ) or other immune cells ( Figure S5C ). Cdk6 was previously implicated in regulating cytokine production (Handschick et al., 2014) , but we found equivalent, or even elevated numbers of neutrophils infiltrating the kidneys of Cdk6 À/À animals on day 5 post-infection ( Figure S6B ), indicating that migratory capacity was unaffected. The higher rates of neutrophil accumulation in knockout mice was likely a reflection of higher fungal burdens in these animals. Furthermore, bone marrow-derived macrophages from WT and Cdk6 null mice produced pro-and anti-inflammatory mediators at similar rates ( Figure S6D) .
Consistent with previous descriptions of sublethal C. albicans infections (Fisher et al., 2011) , histological analysis of infected kidneys demonstrated that, 5 days post-infection, the fungus produced hyphal filaments, which are associated with tissue destruction, and that these hyphae were collecting in excretory lesions in the papillae of the renal pelvis ( Figure 6D ). Immunofluorescence analysis revealed that hyphal masses were more abundant in knockout animals: 90% of Cdk6 À/À mice had detectable hyphae in the renal papillae, compared with 25% of WT mice.
Cdk6 is broadly expressed in hematopoietic and some non-hematopoietic mouse tissues , so its contribution to proper immune defenses could derive from non-myeloid cell activity. To investigate if Cdk6 is required in neutrophils, we restored expression of the kinase in knockout animals by breeding Cdk6 À/À mice with animals expressing Cre recombinase (Cre) under the control of a lysozyme M promoter (LysM-Cre). This driver leads to expression of Cre in cells of the myeloid lineage, including neutrophils, monocytes, and macrophages. Expression of Cre in neutrophils led to excision of the floxed STOP cassette and restored Cdk6 to similar levels as in WT mice ( Figure S6C ). Importantly, genetic rescue of Cdk6 in myeloid cells of knockout mice restored the ability of these mice to mount proper immune responses against C. albicans (Figure 6C) , demonstrating a role for Cdk6 in antimicrobial defense.
DISCUSSION
Neutrophils are terminally differentiated cells that have stopped proliferating. Indeed, an analysis of cell-cycle proteins demonstrated a downregulation of cyclins and CDKs as neutrophils differentiate from hematopoietic precursors into mature cells (Klausen et al., 2004) . Here we show that, despite this downregulation, neutrophils can re-activate some aspects of cell-cycle signaling, most notably CDK4/6, upon mitogenic stimulation. We show that NETosis is accompanied by upregulation of Ki-67, phosphorylation of pRb, lamin A/C, and histone H3S10, as well as duplication of centrosomes and nuclear envelope breakdown. Neutrophil activation does not result in DNA synthesis, condensation of chromosomes or cytokinesis, indicating that cell-cycle re-entry is not occurring. In dividing cells, the cell cycle is tightly controlled and rapidly aborted in response to abnormalities, stress, or disruption of the sequential order of events. Activation of these checkpoints often results in cell death (Malumbres and Barbacid, 2009) . It is interesting to speculate that NETotic cell death also results from triggering of one of these checkpoints. For instance, attempted DNA replication without concomitant production of histones arrests the cell cycle in G 2 (Gunesdogan et al., 2014) . Furthermore, NET formation also requires production of ROS (Fuchs et al., 2007) , which can damage DNA and activate the DNA damage checkpoint in both dividing cells (Malumbres and Barbacid, 2009) and in neutrophils . At this point, it is unclear if CDK4/6 promote NETs via cell-cycle signaling or completely unrelated pathways; therefore the involvement of checkpoints also remains speculative.
ROS can also be mitogenic by activating growth factor receptors (Verbon et al., 2012) , but, in NETosis, NOX2-derived ROS do not appear to be upstream of cell-cycle signaling, as phosphorylation of pRb and lamin A/C proceeds unchanged in neutrophils from CGD patients. CDK4/6 thus function in a parallel pathway to ROS production; these kinases are necessary but not sufficient for NET formation.
NET formation was inhibited by transduction of a peptide mimic derived from the CDK binding domain of p21, providing an indication that a CDK is involved in the process. p21 is an endogenous cell-cycle inhibitor that blocks CDK activity, just like the peptide mimic employed here. Cells from p21 null mice have higher proliferative capacities (Balomenos et al., 2000) and neutrophils from these mice also exhibited elevated rates of NET formation. p21 knockout mice have been reported to have stronger inflammatory reactions (Martin et al., 2016) and, interestingly, p21 knockout mice also spontaneously develop SLE (Balomenos et al., 2000) , a chronic autoimmune disease that has been associated with excessive NET release (Kaplan and Radic, 2012) and accumulation of antibodies against DNA and histones.
Mitogenic signaling in quiescent cells can lead to cell-cycle restart by activating CDK4/6 . Consistent with this idea, we show that CDK4/6 are activated upon mitogenic stimulation of neutrophils, and that these kinases regulate NET formation. Our observation that CDK4/6 are the only cell-cycle CDKs expressed in human neutrophils potentially explains the unusual mix of cell-cycle markers induced during NET formation, since these kinases are active in both phosphorylating pRb in G 1 phase, and inducing centrosome separation in M phase (Hussain et al., 2013) . It remains unclear, however, if CDK4/6 control NETs via cell-cycle substrates or via targets that are unrelated to cell-cycle control. pRb phosphorylation and centrosome separation could thus simply be markers of CDK4/6 activation, rather than being integral to the mechanism of NET release.
CDK6 is predominantly expressed in blood cells where it plays a role in T cell development and lymphomagenesis (Hu et al., 2009 (Hu et al., , 2011 . It regulates cell-cycle re-entry in certain subsets of hematopoietic precursors (Laurenti et al., 2015; Scheicher et al., 2015) , but, despite this, levels of peripheral blood leukocytes, including neutrophils, are normal in Cdk6 knockout mice ( Figure S5 ), probably due to compensation from Cdk4. Alternative roles for Cdk6 as a transcriptional regulator have also been uncovered (Handschick et al., 2014) . It is unlikely that Cdk6 regulates NETs via transcriptional regulation, since NET formation is independent of de novo gene expression . Furthermore, the fact that ROS and cytokine production, as well as surface marker expression, are unperturbed in Cdk6 À/À neutrophils, argues against a defect in differentiation or a general deficiency in inflammatory signaling.
We identify a role for Cdk6 in innate immune defense. Mice lacking this kinase are highly susceptible to infection with the fungal pathogen C. albicans. In acute systemic candidiasis, the immune response is predominantly mediated by neutrophils and not by T cell responses, since mice lacking T cells do not show any increase in susceptibility to disease (Cutler, 1976) . CDK6 was shown to regulate cytokine production in HeLa cells (Handschick et al., 2014) , but we failed to detect a defect in neutrophil recruitment to infected organs. Macrophages, the major producers of cytokines during infections, produced normal levels of these inflammatory mediators despite lacking CDK6. Elevated kidney fungal loads are thus likely a reflection of a defect in neutrophil function, specifically one in NET formation, although the use of the LysM-Cre driver in the rescue experiment means we cannot rule out other impairments in myeloid cells. Cdk6 was shown to regulate macrophage adhesion in response to lipopolysaccharide LPS, and knockout mice are protected against LPS-induced sepsis (Hennessy et al., 2011) . This finding is in line with a role for Cdk6 in NET formation, since NETs are also implicated in the pathology of sepsis (Camicia et al., 2014) .
NETs are important for immune defense, but are also dysregulated in many autoimmune diseases. Intriguingly, a genetic polymorphism in CDK6 has been associated with rheumatoid arthritis (Raychaudhuri et al., 2008) . CDK6 expression levels are also elevated in various types of cancer, and inhibition of this kinase appears to be a promising new antitumor therapy . It is of note that malignancies such as chronic myelogenous leukemia are associated with high levels of NETinduced thrombosis (Demers et al., 2012) . The contribution of (C) C. albicans CFU expressed per gram of kidney tissue in WT, Cdk6 À/À , and conditional rescue Cdk6 À/À ; LysM-Cre + mice, 5 days post-infection with 1 3 10 5 CFU. Lines indicate median. **p < 0.01; *p < 0.05 Mann-Whitney U test. ns, not significant. (D) C. albicans (red) and neutrophils (Ly6G, green) in papillae of renal pelvis (visualized by DNA stain/blue) of WT and Cdk6 À/À mice, day 5 post-infection. Representative image of nine analyzed kidneys per genotype. Scale bar, 200 mm. See also Figure S6 .
CDK6 to cancer may thus be 2-fold: cell-cycle dysregulation contributing to tumorigenesis as well as increased NET formation by myeloid cell precursors leading to thrombosis, the second most common cause of death in cancer patients (Rickles et al., 1992) . Use of CDK4/6 inhibitors in cancer therapy may consequently lower rates of thrombosis, but also dampen immune responses in patients.
Interestingly, other instances exist where cell-cycle signaling in postmitotic cells has been linked to disease (Herrup and Yang, 2007) . In the brain, neurons can inappropriately re-activate the cell cycle, which leads to cell death just as it does in neutrophils. Cell death resulting from neuron cell-cycle re-entry has been linked to several neurodegenerative diseases, including Alzheimer's disease and amyotrophic lateral sclerosis (Busser et al., 1998; Herrup and Yang, 2007) . Dysregulation of cell-cycle proteins in postmitotic neurons and neutrophils can thus be viewed as a unifying disease principle in neurodegenerative and inflammatory disorders.
In summary, NET formation, an antimicrobial form of cell death, is controlled by the activation of the cell-cycle kinases CDK4/6. During infection, lymphocytes activate the cell cycle to rapidly increase their numbers and thus fulfill their memory or cytotoxic functions. We show that, in neutrophils, similar pathways are used for regulating the NETotic cell death program, with essential consequences for immunopathology and defense against pathogens. These findings open up avenues for therapeutic interventions in NET-related diseases.
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